MORGAN CARTER: Open Payments
NPI 1972127173 · TOCCOA, GA. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$854 in 48 payments from 17 companies in 2025. Trend: 2023 $913 · 2024 $970 · 2025 $854
Food & beverage: $854
| Company | Payments | Amount |
|---|---|---|
| ABBVIE INC. | 12 | $162 |
| Indivior Inc. | 7 | $111 |
| Boehringer Ingelheim Pharmaceuticals, Inc. | 5 | $94 |
| Bayer Healthcare Pharmaceuticals Inc. | 3 | $67 |
| PFIZER INC. | 4 | $61 |
| AstraZeneca Pharmaceuticals LP | 3 | $60 |
| Novo Nordisk Inc | 3 | $56 |
| Calliditas Therapeutics US Inc. | 1 | $36 |
| SHIELD THERAPEUTICS INC | 2 | $34 |
| Eisai Inc. | 1 | $31 |
Products named: SUBLOCADE, JARDIANCE, VRAYLAR, Kerendia, FARXIGA, QULIPTA, ELIQUIS, Ozempic.
Industry payments across GA — which companies pay providers there.
